Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

A new case report titled “Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report” has been published in Oncotarget.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart